Prolira (Utrecht, the Netherlands) announced today that the FDA has cleared its brain state monitor to help diagnose acute encephalopathy in older hospital patients. DeltaScan is for hospitalized patients aged 60 and older. Prolira said it provides a quick and objective measurement of acute brain failure even before symptoms appear. The measurements enable sped-up treatment, […]